CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 500 enrolled
Drug / intervention
etoricoxibdrug
Likely dose
etoricoxib 60 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00757627
NCT00757627Phase 4Completed
CompareCT.gov

Patient-reported Outcomes With Etoricoxib in Real Life

Organon and Co·interventional·Posted Sep 23, 2008·Updated Feb 9, 2022

In Brief

A Phase 4 clinical trial evaluating etoricoxib for Pain. Completed, enrolled 500 participants.

Detailed Summary

The purpose of this study is to collect disease burden of OA and the effectiveness and patient satisfaction of treatment by Etoricoxib in the normal practice setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 23, 2008
Enrollment StartDec 1, 2007
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.8 years ago

Interventions

etoricoxibdrug

etoricoxib 60 mg QD for 4 weeks.